Endocrinology
From the Journals
Nearly one in five U.S. adolescents have prediabetes
Prediabetes is more common in male adolescents than in female adolescents in the United States.
Conference Coverage
DAPA-HF: Dapagliflozin benefits regardless of age, HF severity
PHILADELPHIA – The SGLT2 inhibitor had similar efficacy in the elderly, and across the spectrum of baseline symptom status.
Conference Coverage
Elagolix is effective second-tier treatment for endometriosis-associated dysmenorrhea
PHILADELPHIA – It has a very low adverse event profile and is well tolerated.
Conference Coverage
Findings confirm link between methimazole and risk for acute pancreatitis
CHICAGO – However, there is no evidence of a cumulative dose effect.
Conference Coverage
DAPA-HF: Dapagliflozin’s HFrEF efficacy confirmed in nondiabetics
PHILADELPHIA –
News from the FDA/CDC
FDA panel supports Vascepa expanded indication for CVD reduction
Icosapent ethyl (Vascepa), purified eicosapentaenoic acid, got unanimous support from an FDA panel for a new indication of reducing CVD events.
Latest News
Small nodules, big problems: AI's role in thyroid nodule diagnosis
A novel algorithm for benign thyroid nodules showed good sensitivity and specificity.
Conference Coverage
New model for CKD risk draws on clinical, demographic factors
The equation has demonstrated high discrimination and variable calibration across a range of populations.
Latest News
Levothyroxine dose for checkpoint inhibitor toxicity may be too high
CHICAGO – Dosing need not be automatically boosted when starting checkpoint inhibitor therapy.
Latest News
T3 levels are higher in combatants with PTSD
CHICAGO – Chronic catecholamine elevation may have a role in the thyroid hormone abnormality.
Conference Coverage
Hormone therapy in transgender patients is safe for bone
ORLANDO – An analysis of the available literature on bone health in transwomen and transmen receiving hormone therapy showed that transwomen had...